Madrigal Pharmaceuticals, Inc. company logo
Madrigal Pharmaceuticals, Inc. logo

Madrigal Pharmaceuticals, Inc. (MDGL) Selling, General & Administrative Expenses

Annual SG&A

$0.00$108.15M-100.00%

Summary

Current Value
As of today, MDGL annual SG&A is $0.00, down -100.00% on
Historical Performance
MDGL annual SG&A is down -100.00% over the past 3 years, and down -100.00% over the past 5 years
All-Time High Comparison
MDGL annual SG&A is currently -100.00% below its historical high of $108.15M set on
3-Year Low Comparison
MDGL annual SG&A vs 3-year low value is unknown
Sector Comparison
MDGL annual SG&A is higher than 39.37% of companies in Healthcare sector

SG&A Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

MDGL Performance
MetricDateValue1Y3Y5Y15Y
Annual SG&A$0.00-100.0%-100.0%-100.0%-100.0%
Quarterly SG&A$209.12M+94.4%+1622.4%+3706.3%+7970.9%
TTM SG&A-$7.63B-2340.9%-10000.0%-10000.0%-10000.0%
Price$510.53+50.6%+69.7%+356.2%+116.1%
Annual Operating Expenses$671.78M+76.5%+177.0%+607.3%+954.5%
Annual Operating Profit-$497.88M-30.9%-105.3%-424.2%-718.2%
Annual D&A$1.10M+108.0%+170.6%+878.6%-55.5%
Annual Revenue$180.13M+100.0%+100.0%+100.0%+24.9%

SG&A Highs

MDGL Annual SG&A Highs Comparison
PeriodHighDateCurrent
3Y$108.15M-100.0%
5Y$108.15M-100.0%
All$108.15M-100.0%

SG&A Lows

MDGL Annual SG&A Lows Comparison
PeriodLowDateCurrent
3Y$0.00N/A
5Y$0.00N/A
All$0.00N/A

SG&A History

YearValueChange
$0.00-100.0%
$108.15M+124.7%
$48.13M+29.0%
$37.32M+70.7%
$21.86M-3.5%
$22.65M+48.1%
$15.29M+99.3%
$7.67M-17.4%
$9.29M+1,052.9%
$805.80K-94.9%
$15.75M+0.3%
$15.70M+34.5%
YearValueChange
$11.68M+1.1%
$11.55M+0.9%
$11.45M-9.5%
$12.65M-14.2%
$14.74M-1.3%
$14.93M+72.7%
$8.65M-23.3%
$11.28M+52.8%
$7.38M+40.3%
$5.26M+235.3%
$1.57M+1,165.3%
$124.00K-

FAQ

  • What is the current annual SG&A of MDGL?

    As of today, MDGL annual SG&A is $0.00

  • What is 1-year change in MDGL annual SG&A?

    MDGL annual SG&A is down -100.00% year-over-year

  • What is 3-year change in MDGL annual SG&A?

    MDGL annual SG&A is down -100.00% over the past 3 years

  • How far is MDGL annual SG&A from its all-time high?

    MDGL annual SG&A is currently -100.00% below its historical high of $108.15M set on December 31, 2023

  • How does MDGL annual SG&A rank versus sector peers?

    MDGL annual SG&A is higher than 39.37% of companies in Healthcare sector

  • When is MDGL next annual earnings release?

    The next annual earnings release for MDGL is on

Selling, General & Administrative Expenses Formula

SG&A = − R&D

Data Sources & References

  1. MDGL Official Website www.madrigalpharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1157601/000162828025048559/0001628280-25-048559-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828025007980/0001628280-25-007980-index.htm
  4. MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
  5. MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl